JPRN-UMIN000023802
Completed
未知
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer - A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hirosaki University
- Enrollment
- 28
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) T3N1 2\) Superior vena cava syndrome. 3\) Lymph node metastases of opposite side hilum, malignant pleuritis, malignant pericarditis, lymphangitis. 4\) With active double cancer. 5\) Active infection. 6\) Other serious disease condition (idiopathic pulmonary fibrosis, interstitial lung disease, renal failure, liver failure, Cerebral Vascular Disorder, unstable angina, cardiac infarction, Myocardial Infarction, poorly controlled diabetes mellitus,etc). 7\) Grade2\< peripheral neuropathy. 8\) Severe drug allergy. 9\) Pregnancy or lactation. 10\) Patient whose participation in the trial is judged to be inappropriate by the attending doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
Completed
Not Applicable
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancerJPRN-UMIN000010324orth Japan Lung Cancer Study Group35
Completed
Phase 2
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
Completed
Not Applicable
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80
Recruiting
Not Applicable
Phase II study of carboplatin, weekly paclitaxel and bevacizumab for advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumoniaadvanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumoniaJPRN-UMIN000018322IP lung cancer study group35